• Cannabis Drug Shows Promise in Treating Schizophrenia
• CBD as an antipsychotic drug  
• Cannabidiol as a potential treatment for psychosis 
• CBD enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
• Medical use of cannabis. CBD: A new light for schizophrenia?
• A critical review of the antipsychotic effects of CBD: 30 years of a translational investigation
• Peripheral endocannabinoid system dysregulation in first-episode psychosis 
• Cannabinoids and schizophrenia 
• Antipsychotic-like effects of cannabidiol and rimonabant
• CBD monotherapy for treatment-resistant schizophrenia
• Cannabis with high CBD content is associated with fewer psychotic experiences
• Marijuana compound treats schizophrenia with few side effects: Clinical trial 
• Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?
• Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments